Get started with Re5 in your clinic
Evidence review & live demonstration: We walk you through the clinical data and show you the device in action
Patient monitoring software: Track treatment progress and compliance (retrospectively)
Clinical implementation guidance: Practical help integrating Re5 into your existing treatment pathways
Interested in research collaboration?
Investigator-initiated study support: Device supply, technical setup, and regulatory documentation for independent clinical research
Access to existing clinical data: Published studies and summary of Clinical Evaluation Report available on request
Peer-reviewed clinical evidence
Backed by science
6+
Peer-reviewed clinical publications - including sham-controlled RCTs, dose-response studies, independent multicenter trials, and real-world outcomes data
34% / 61%
Sham-controlled remission / response in strictly defined TRD (≥2 failed antidepressant courses) in a 5-week treatment protocol, n=50 (Martiny 2010)
~70%
Remission in an 8-week treatment protocol in a dose-response RCT in TRD, n=58 (Straasø 2014)
Zero
Serious Adverse Events in 20,000+ sessions (CER)
29%
Remission in patients who did not respond to ECT, n=19 (Larsen 2020)
100%
Remission in relapsed remitters at 2-year follow-up, n=13 (Bech 2015)
